Concourse Financial Group Securities, Inc. Aadi Bioscience, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $1.64 Billion
- Q3 2024
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding AADI
# of Institutions
66Shares Held
14.1MCall Options Held
9.4KPut Options Held
2.5K-
Avoro Capital Advisors LLC New York, NY2.85MShares$5.98 Million0.06% of portfolio
-
Bml Capital Management, LLC Zionsville, IN2MShares$4.2 Million2.42% of portfolio
-
Acuta Capital Partners, LLC Belmont, CA1.85MShares$3.88 Million2.91% of portfolio
-
Satter Management Co., L.P.1.63MShares$3.42 Million4.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA766KShares$1.61 Million0.0% of portfolio
About Aadi Bioscience, Inc.
- Ticker AADI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,016,800
- Market Cap $44.1M
- Description
- Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...